Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-25-005864

SVP, Chief Accounting Officer sold 1,562 shares at $9.15 ($14,291)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sabatini Brent SVP, Chief Accounting Officer 2025-02-13 Sale 10b5-1 −1,562 $9.15 $14,291 28,189 D
Open-market sales · 1,562 sh · avg $9.15 · $14,291
Loading xslF345X05/wk-form4_1739576505.xml…